DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Inovio Pharmaceuticals Q4 EPS $(0.38) Misses $(0.24) Estimate, Sales $279K Miss $2.32M Estimate

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.24) by 58.33 percent. This is a 11.76 percent decrease over losses of $(0.34) per

Benzinga · 03/12/2020 20:24

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.24) by 58.33 percent. This is a 11.76 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $279 thousand which missed the analyst consensus estimate of $2.32 million by 87.97 percent. This is a 88.85 percent decrease over sales of $2.503 million the same period last year.